Crinetics Pharmaceuticals, Inc.CRNXNASDAQ

Revenue (LTM)

$8M

+640.7% YoY

Net Income (LTM)

$-465M

-55.9% YoY

Free Cash Flow

$-384M

Revenue CAGR (5Y)

+155.3%

Marginsdeclining

FCF($0.4B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	1	5↑339.4%	4↓15.3%	1↓74.1%	8↑640.7%
Gross Profit	1	5↑339.4%	4↓15.3%	1↓74.1%	3↑162.8%
Operating Income	-108	-168↓55.9%	-223↓32.6%	-339↓52.2%	-517↓52.5%
Net Income	-108	-164↓52.3%	-215↓30.9%	-298↓39.1%	-465↓55.9%
EBITDA	-107	-167↓56.3%	-222↓32.7%	-336↓51.7%	-461↓37.2%
EPS Diluted	-2.80	-3.15↓12.5%	-3.69↓17.1%	-3.69↓0.0%	-4.95↓34.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	201	33↓83.7%	55↑68.0%	265↑381.9%	102↓61.6%
Total Current Assets	345	345↑0.1%	574↑66.3%	1,375↑139.6%	1,048↓23.8%
Total Assets	351	352↑0.3%	635↑80.4%	1,435↑125.8%	1,135↓20.8%
Total Current Liabilities	16	28↑73.3%	44↑58.5%	60↑35.8%	85↑42.5%
Total Liabilities	19	36↑88.0%	96↑168.5%	110↑14.1%	143↑30.6%
Total Equity	332	316↓4.7%	539↑70.4%	1,325↑145.7%	992↓25.1%
Total Debt	3	3↑0.0%	52↑1582.2%	52↓0.0%	49↓6.2%
Net Debt	-198	-30↑85.0%	-3↑89.3%	-213↓6615.8%	-53↑75.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-89	-115↓30.0%	-166↓44.4%	-226↓35.9%	-378↓67.2%
Capital Expenditure	-0	-2↓279.8%	-5↓183.1%	-4↑18.0%	-6↓49.9%
Free Cash Flow	-89	-117↓31.3%	-171↓46.3%	-230↓34.4%	-384↓67.0%
Stock-Based Comp	17	28↑62.9%	41↑44.8%	69↑69.5%	91↑31.2%
Net Change in Cash	108	-167↓255.4%	22↑113.3%	210↑843.3%	-164↓178.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance